Literature DB >> 17239130

Severe cryptosporidiosis in a seven-year-old renal transplant recipient: case report and review of the literature.

David K Hong1, Cynthia J Wong, Kathleen Gutierrez.   

Abstract

Cryptosporidium is an intracellular protozoa that can cause gastroenteritis in humans. In immunocompromised hosts, infection can be severe, leading to life-threatening persistent diarrhea. There is limited experience in treating this infection in solid organ transplants. Although newer drugs active against Cryptosporidium exist, they are only licensed in the USA for treatment of immunocompetent hosts. Here we describe a seven-year-old renal transplant recipient with severe cryptosporidiosis. He had a protracted course of diarrhea of up to 2 L/day. He was successfully managed with combination antimicrobial therapy including nitazoxanide, paromomycin, and azithromycin. In conjunction with this regimen, he had a reduction in immunosuppression and complete bowel rest. His stool pattern normalized in four weeks and he has had no recurrence after six months of follow up.

Entities:  

Mesh:

Year:  2007        PMID: 17239130     DOI: 10.1111/j.1399-3046.2006.00593.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  12 in total

1.  Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis.

Authors:  Sangun Lee; Melanie Ginese; Gillian Beamer; Hillary R Danz; Donald J Girouard; Susan P Chapman-Bonofiglio; Minhee Lee; Matthew A Hulverson; Ryan Choi; Grant R Whitman; Kayode K Ojo; Samuel L M Arnold; Wesley C Van Voorhis; Saul Tzipori
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

2.  Antibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice.

Authors:  Michael Imboden; Michael W Riggs; Deborah A Schaefer; E Jane Homan; Robert D Bremel
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

3.  Cryptosporidiosis in paediatric renal transplantation.

Authors:  Flavio Bandin; Theresa Kwon; Marie-Denise Linas; Vincent Guigonis; Alexis Valentin; Sophie Cassaing; Agnes Carol; Arnaud Garnier; Veronique Baudouin; Stéphane Decramer
Journal:  Pediatr Nephrol       Date:  2009-11       Impact factor: 3.714

Review 4.  Clinical significance of enteric protozoa in the immunosuppressed human population.

Authors:  D Stark; J L N Barratt; S van Hal; D Marriott; J Harkness; J T Ellis
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

5.  Genotyping of Cryptosporidium isolates from human clinical cases in Poland.

Authors:  Anna Bajer; Małgorzata Bednarska; Simone M Cacciò; Beata Wolska-Kuśnierz; Edyta Heropolitanska-Pliszka; Ewa Bernatowska; Małgorzata Wielopolska; Anna Paziewska; Renata Welc-faleciak; Edward Siński
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

6.  Cryptosporidiosis-an overview.

Authors:  Gordon J Leitch; Qing He
Journal:  J Biomed Res       Date:  2012-02-21

7.  A day at the pool.

Authors:  Kervina Vythelingum; John Cheesbrough; Alexander Woywodt
Journal:  Clin Kidney J       Date:  2012-03-14

Review 8.  Cryptosporidium infection in solid organ transplantation.

Authors:  Diana F Florescu; Uriel Sandkovsky
Journal:  World J Transplant       Date:  2016-09-24

9.  Addressing Cryptosporidium Infection among Young Children in Low-Income Settings: The Crucial Role of New and Existing Drugs for Reducing Morbidity and Mortality.

Authors:  David A Shoultz; Eugenio L de Hostos; Robert K M Choy
Journal:  PLoS Negl Trop Dis       Date:  2016-01-28

10.  The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.

Authors:  Sangun Lee; Melanie Harwood; Don Girouard; Marvin J Meyers; Mary A Campbell; Gillian Beamer; Saul Tzipori
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.